Tony Ho

Dr. Tony W. Ho is an Independent Director at iTeos Therapeutics, Inc., an Independent Director at Engrail Therapeutics, Inc., an Executive VP, Head-Research & Development at CRISPR Therapeutics AG, an Adjunct Associate Professor at University of Pennsylvania and an Assistant Professor-Neurology at The Johns Hopkins University. He is on the Board of Directors at iTeos Therapeutics, Inc. and Engrail Therapeutics, Inc. Dr. Ho was previously employed as a Senior Vice President & Head-Oncology by Astrazeneca AG, a Chief Scientific Officer by Neuronyx, Inc., a Head-Merck Research Laboratories by Merck & Co., Inc., a Head-Neurology & Ophthalmology by Merck Research Laboratories Massachusetts LLC, and an Assistant Professor by The Johns Hopkins Hospital, Inc. He received his undergraduate degree from the University of California, Los Angeles and a doctorate degree from The Johns Hopkins University School of Medicine.